#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13884	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2101	656.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1454	1454	C	789	C	727	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13884	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2101	656.1	0	HET	.	.	.	C207T	.	207	207	C	477	477	C	807	C,T	598,150	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25802	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3553	723.9	0	.	n	.	0	T695C	SNP	695	695	T	1038	1038	C	759	C	714	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25802	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3553	723.9	0	.	n	.	0	A1638G	SNP	1638	1638	A	1981	1981	G	789	G,T	752,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25802	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3553	723.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2314	2314	C	791	C	736	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25802	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3553	723.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2388	2388	A	783	A,G	741,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25802	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3553	723.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2940	2940	C	785	C	737	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	4	blaTEM	861	251	100.0	blaTEM.l15.c30.ctg.1	251	1.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1854	folP	855	855	100.0	folP.l15.c4.ctg.1	1567	117.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1081	1083	AGC	171;174;174	A;G;C	162;162;162	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4814	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3337	143.7	1	SNP	p	S91F	1	.	.	271	273	TTC	557	559	TTC	165;166;163	T;T;C	153;152;150	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4814	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3337	143.7	1	SNP	p	D95G	1	.	.	283	285	GGC	569	571	GGC	162;163;162	G;G;C	150;150;151	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4814	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3337	143.7	1	SNP	p	G95N	0	.	.	283	285	GGC	569	571	GGC	162;163;162	G;G;C	150;150;151	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1430	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1388	102.7	1	SNP	p	G45D	0	.	.	133	135	GGC	541	543	GGC	150;145;146	G;G;C	142;138;140	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	740	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1016	72.6	0	.	n	.	0	A197.	DEL	197	197	A	562	562	A	175	A	168	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5460	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2988	182.0	1	SNP	p	D86N	0	.	.	256	258	GAC	623	625	GAC	204;204;202	G;A;C	193;191;192	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5460	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2988	182.0	1	SNP	p	R87W	0	.	.	259	261	CGT	626	628	CGT	204;206;208	C;G;T	194;192;193	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5460	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2988	182.0	1	SNP	p	S87R	1	.	.	259	261	CGT	626	628	CGT	204;206;208	C;G;T	194;192;193	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5460	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2988	182.0	1	SNP	p	R87I	0	.	.	259	261	CGT	626	628	CGT	204;206;208	C;G;T	194;192;193	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5460	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2988	182.0	1	SNP	p	S88P	0	.	.	262	264	TCC	629	631	TCC	211;213;212	T;C;C	198;201;200	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3554	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2426	145.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1449	1451	GGC	191;193;194	G;G,A;C	168;168,1;169	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3764	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	155.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1301	1303	GCC	211;209;209	G;C;C	184;185;184	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3764	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	155.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1304	1306	ATG	205;207;206	A;T;G	183;182;179	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3764	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	155.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1316	1318	ACC	195;193;191	A;C;C	178;177;176	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3764	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	155.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1316	1318	ACC	195;193;191	A;C;C	178;177;176	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3764	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	155.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1817	1819	ACC	186;185;186	A;C;C,T	174;175;176,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3764	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	155.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1871	1873	GCG	191;193;191	G;C;G	178;183;183	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3764	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	155.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1871	1873	GCG	191;193;191	G;C;G	178;183;183	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3764	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	155.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1994	1996	GGT	171;171;172	G;G;T	148;153;151	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3764	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	155.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2003	2005	AGC	172;170;169	A;G;C	149;148;149	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3764	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	155.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2021	2023	CCG	138;141;143	C,G;C,G;G	103,6;107,2;109	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5604	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2966	188.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1541	1543	CCG	207;210;211	C;C;G,A	182;190;190,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2170	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1686	127.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	523	523	C	144	C	133	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	288	porB1a	984	271	91.51	porB1a.l15.c17.ctg.1	377	23.6	0	.	p	.	0	A251V	NONSYN	751	753	GCG	41	43	GTA	30;30;30	G;T;A	25;25;25	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	288	porB1a	984	271	91.51	porB1a.l15.c17.ctg.1	377	23.6	0	.	p	.	0	S271T	NONSYN	811	813	TCG	101	103	ACT	54;53;48	A;C;T	49;47;43	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	288	porB1a	984	271	91.51	porB1a.l15.c17.ctg.1	377	23.6	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	107	109	GAT	42;41;39	G;A;T	39;39;38	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	288	porB1a	984	271	91.51	porB1a.l15.c17.ctg.1	377	23.6	0	.	p	.	0	D276N	NONSYN	826	828	GAT	116	118	AAC	39;39;40	A;A;C	37;38;36	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	288	porB1a	984	271	91.51	porB1a.l15.c17.ctg.1	377	23.6	0	.	p	.	0	N277H	NONSYN	829	831	AAC	119	121	CAC	40;40;40	C;A;C	39;38;39	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	288	porB1a	984	271	91.51	porB1a.l15.c17.ctg.1	377	23.6	0	.	p	.	0	R307E	NONSYN	919	921	AGA	209	211	GAA	9;9;9	G;A;A	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	288	porB1a	984	271	91.51	porB1a.l15.c17.ctg.1	377	23.6	0	.	p	.	0	T311A	NONSYN	931	933	ACA	221	223	GCA	11;11;11	G;C;A	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	288	porB1a	984	271	91.51	porB1a.l15.c17.ctg.1	377	23.6	0	.	p	.	0	E312D	NONSYN	934	936	GAA	224	226	GAC	11;11;11	G;A;C	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	288	porB1a	984	271	91.51	porB1a.l15.c17.ctg.1	377	23.6	0	.	p	.	0	F314I	NONSYN	940	942	TTC	230	232	ATC	11;11;11	A;T;C	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	288	porB1a	984	271	91.51	porB1a.l15.c17.ctg.1	377	23.6	0	.	p	.	0	A316S	NONSYN	946	948	GCG	236	238	TCG	11;11;10	T;C;G	11;11;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	288	porB1a	984	271	91.51	porB1a.l15.c17.ctg.1	377	23.6	0	.	p	.	0	V318A	NONSYN	952	954	GTC	242	244	GCC	10;11;12	G;C;C	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	288	porB1a	984	271	91.51	porB1a.l15.c17.ctg.1	377	23.6	0	.	p	.	0	G319S	NONSYN	955	957	GGC	245	247	AGC	12;12;12	A,C;G;C	9,1;9;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	288	porB1a	984	271	91.51	porB1a.l15.c17.ctg.1	377	23.6	0	.	p	.	0	G320A	NONSYN	958	960	GGT	248	250	GCC	12;11;11	G;C;C	10;10;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	288	porB1a	984	271	91.51	porB1a.l15.c17.ctg.1	377	23.6	0	.	p	.	0	G322V	NONSYN	964	966	GGT	254	256	GTT	11;11;11	G;T;T	9;10;10	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2788	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1589	173.5	1	SNP	p	G120K	1	.	.	358	360	AAG	645	647	AAG	211;213;212	A;A;G	201;205;200	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2788	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1589	173.5	1	SNP	p	N121D	0	.	.	361	363	AAC	648	650	AAC	214;207;206	A;A;C	204;195;194	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2788	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1589	173.5	1	SNP	p	A121N	1	.	.	361	363	AAC	648	650	AAC	214;207;206	A;A;C	204;195;194	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10418	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4786	216.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1084	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1083	99.5	1	SNP	p	V57M	1	.	.	169	171	ATG	580	582	ATG	208;207;206	A;T;G	197;197;196	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
